In conclusion, our findings have major implications for pathogenic mechanisms in AD since the blocking peptide binds to specific populations of Aβ oligomers, interferes with their toxic aggregation process and further impedes the formation of Aβo that prominently target synapses. The gene discussed is ABO; the disease is Alzheimer disease.